WA

Written & reviewed by WhatAreAllergies Editorial Team

Editorial Review

Health Editors & Medical Writers · Allergy, Immunology & Clinical Health Content

WhatAreAllergies.com

Updated May 2026·Annual review cycle

Our editorial process: All content on WhatAreAllergies.com is written and reviewed by our editorial team following published guidelines from ACAAI, AAAAI, WAO, and ARIA. Content is updated annually or when major guidelines change. This content is educational only — not a substitute for professional medical advice. We do not accept advertising influence on editorial content. Read our editorial policy →

Quick Answer

Allergic reactions are classified into four types by the Gell and Coombs system. Type I reactions are IgE-mediated and immediate (classic allergy). Type II involves antibodies attacking cells. Type III involves immune complexes. Type IV is T-cell-mediated and delayed, as in contact dermatitis. Most common allergy is Type I.

Type I: Immediate IgE-Mediated Hypersensitivity

Type I hypersensitivity is what most people mean when they say 'allergy.' It involves allergen-specific IgE antibodies bound to mast cells and basophils. Within seconds to minutes of allergen re-exposure, IgE crosslinking triggers mast cell degranulation, releasing histamine, tryptase, leukotrienes, and prostaglandins. Symptoms include urticaria, rhinitis, conjunctivitis, angioedema, asthma, and anaphylaxis.

Type I reactions are diagnosed by skin prick testing and specific IgE blood tests. Common causes include foods (peanuts, shellfish, milk), environmental allergens (pollen, dust mites, pet dander), insect venom, latex, and medications. Anaphylaxis — the most severe Type I reaction — requires immediate epinephrine treatment.

Type II and Type III: Antibody-Mediated Reactions

Type II hypersensitivity involves IgG or IgM antibodies that bind directly to cell surfaces or tissue antigens, activating complement and causing cell destruction. Examples relevant to allergic disease include drug reactions where a medication binds to red blood cells and triggers their destruction (hemolytic anemia). Goodpasture syndrome and some transfusion reactions are Type II.

Type III hypersensitivity involves immune complex formation — IgG antibodies binding to circulating antigens and forming complexes that deposit in tissues, activating complement. Serum sickness (from heterologous antisera) and some drug reactions are examples. Type III reactions cause symptoms 1–3 weeks after exposure, unlike the immediate Type I response.

Type IV: Delayed T-Cell-Mediated Hypersensitivity

Type IV hypersensitivity is fundamentally different from the IgE-mediated allergy: it involves T lymphocytes rather than antibodies and produces reactions that peak 48–72 hours after exposure. Allergic contact dermatitis — from nickel jewelry, poison ivy, latex gloves, fragrances, or preservatives — is the most common Type IV reaction in clinical practice.

During Type IV sensitization, antigen-presenting cells present hapten-protein complexes to naive T cells in lymph nodes, generating memory effector T cells. On re-exposure, these memory T cells accumulate in the skin at the contact site, release inflammatory cytokines, and recruit macrophages — producing the characteristic itchy, weeping rash that appears 24–72 hours after contact.

Patch testing — not skin prick testing — is used to diagnose Type IV contact allergy. A panel of 30–70 standardized contact allergens is applied under adhesive patches for 48 hours, and reactions are read at 48 and 96 hours. Treatment involves identifying and avoiding the causative allergen plus topical corticosteroids for active dermatitis.

Mixed and Pseudoallergic Reactions

Some reactions do not fit neatly into the Gell and Coombs classification. Aspirin and NSAID hypersensitivity can cause urticaria and anaphylaxis through non-IgE mechanisms by inhibiting cyclooxygenase and diverting arachidonic acid into the leukotriene pathway. Radiocontrast media reactions occur through direct mast cell activation without IgE. These are called pseudoallergic or anaphylactoid reactions — clinically similar to Type I but managed differently.

Key Takeaways

  • Type I (IgE-mediated, immediate): classic allergy — urticaria, rhinitis, anaphylaxis.
  • Type II (antibody-mediated): IgG/IgM attacks cells — drug-induced hemolysis.
  • Type III (immune complex): complement activation from deposited complexes — serum sickness.
  • Type IV (T-cell-mediated, delayed): contact dermatitis peaking at 48–72 hours — diagnosed by patch test.
  • NSAID reactions and contrast dye reactions are pseudoallergic (non-IgE) but can mimic anaphylaxis.

Frequently Asked Questions

Is contact dermatitis a true allergy?
Yes. Allergic contact dermatitis is a Type IV hypersensitivity reaction mediated by T lymphocytes. It is immunologically specific (only the sensitizing allergen triggers it), reproducible, and distinct from irritant contact dermatitis which requires no prior sensitization and can occur in anyone with sufficient exposure.
Why does an allergic reaction get worse over time?
With Type I reactions, increasing quantities of allergen-specific IgE on mast cells lower the threshold needed to trigger degranulation, and the late-phase response recruits more eosinophils and T cells that amplify airway and skin inflammation with each exposure. This explains why some patients develop more severe reactions after years of minor ones.
Can you have more than one type of allergic reaction to the same substance?
Yes. Some individuals have both Type I and Type IV reactions to the same allergen. Latex allergy is a well-known example — patients can have immediate IgE-mediated reactions (Type I) from glove contact and delayed contact dermatitis (Type IV) from chemical additives in latex simultaneously.

About the Medical Team

WA
Medical Review

WhatAreAllergies Editorial Team,

Health Editors & Medical Writers

Allergy, Immunology & Clinical Health Content

WhatAreAllergies.com
WA
Written by

WhatAreAllergies Editorial Team,

Health Content Editor

Clinical Allergy & Immunology Content

WhatAreAllergies.com

Content is written by our editorial team following current clinical guidelines from ACAAI, AAAAI, and WAO. Educational only — always consult a qualified healthcare provider for medical advice. View editorial policy →

Medical References & Citations

  1. 1
    guideline2006

    Sampson HA, et al. "Second symposium on the definition and management of anaphylaxis: Summary report" — Journal of Allergy and Clinical Immunology.

    View source
  2. 2
    database2025

    American College of Allergy, Asthma & Immunology (ACAAI) "Allergy Facts and Figures" — ACAAI Clinical Resources.

    View source
  3. 3
    review2025

    World Allergy Organization (WAO) "White Book on Allergy — 2025 Update" — World Allergy Organization.

    View source
  4. 4
    guideline2024

    National Institute of Allergy and Infectious Diseases (NIAID) "Clinical Guidelines for the Diagnosis and Management of Food Allergy" — National Institutes of Health.

    View source
  5. 5
    guideline2024

    Muraro A, et al. "EAACI food allergy and anaphylaxis guidelines: Diagnosis and management of food allergy" — Allergy — European Journal of Allergy and Clinical Immunology.

This content reflects clinical guidelines current as of the last review date shown above. Always consult a qualified healthcare provider for personalized medical advice.